The Vancouver lung cancer risk prediction model: Assessment by using a subset of the national lung screening trial cohort
PublisherRadiological Society of North America Inc.
MetadataShow full item record
AbstractPurpose: To assess the likelihood of malignancy among a subset of nodules in the National Lung Screening Trial (NLST) by using a risk calculator based on nodule and patient characteristics. Materials and Methods: All authors received approval for use of NLST data. An institutional review board exemption and a waiver for informed consent were granted to the author with an academic appointment. Nodule characteristics and patient attributes with regard to benign and malignant nodules in the NLST were applied to a nodule risk calculator from a group in Vancouver, Canada. Patient populations and their nodule characteristics were compared between the NLST and Vancouver cohorts. Multiple thresholds were tested to distinguish benign nodules from malignant nodules. An optimized threshold value was used to determine positive and negative predictive values, and a full logistic regression model was applied to the NLST data set. Results: Sufficient data were available for 4431 nodules (4315 benign nodules and 116 malignant nodules) from the NLST data set. The NLST and Vancouver data sets differed in that the former included fewer nodules per study, fewer nonsolid nodules, and more nodule spiculation and emphysema. A composite risk score threshold of 10% was determined to be optimal, demonstrating sensitivity, specificity, positive predictive value, and negative predictive value of 85.3%, 93.9%, 27.4%, and 99.6%, respectively. The receiver operating characteristic curve for the full regression model applied to the NLST database demonstrated an area under the receiver operating characteristic curve of 0.963 (95% confidence interval: 0.945, 0.974). Conclusion: Application of an NLST data subset to the Vancouver risk calculator yielded a high discriminant value, which supports the use of a risk calculator method as a valuable approach to distinguish between benign and malignant nodules.
Vancouver risk calculator
Tomography, X-Ray Computed--methods
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85017133188&doi=10.1148%2fradiol.2016152627&partnerID=40&md5=15c2d7289060e3d25557648c5d250895; http://hdl.handle.net/10713/11261
- Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial.
- Authors: White CS, Dharaiya E, Dalal S, Chen R, Haramati LB
- Issue date: 2019 Apr
- Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
- Authors: Yoo H, Kim KH, Singh R, Digumarthy SR, Kalra MK
- Issue date: 2020 Sep 1
- Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
- Authors: Hammer MM, Palazzo LL, Kong CY, Hunsaker AR
- Issue date: 2019 Nov
- CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases.
- Authors: Yip R, Henschke CI, Yankelevitz DF, Smith JP
- Issue date: 2014 Nov
- Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study.
- Authors: Liu Y, Wang H, Li Q, McGettigan MJ, Balagurunathan Y, Garcia AL, Thompson ZJ, Heine JJ, Ye Z, Gillies RJ, Schabath MB
- Issue date: 2018 Jan